Implantica AG (publ) announced that the RefluxStop procedure to treat acid reflux is now being successfully implemented at Spire Manchester Hospital, part of the Spire Healthcare Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.4 SEK | +0.37% | -5.35% | +14.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.64% | 706M | |
+73.19% | 12.38B | |
-18.16% | 7.61B | |
+14.34% | 7.11B | |
+4.77% | 5.83B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-19.09% | 4.02B | |
-34.91% | 2.16B | |
+1.24% | 2.01B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica AG Announces Spire Manchester Hospital in UK Begins Operating with RefluxStop™